Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249206 | SCV000309831 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000249206 | SCV000338634 | benign | not specified | 2015-12-23 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625316 | SCV000744902 | benign | Neuronal ceroid lipofuscinosis 13 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000675400 | SCV000841685 | benign | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311381 | SCV000845987 | benign | Inborn genetic diseases | 2016-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000675400 | SCV000985857 | benign | not provided | 2018-06-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000625316 | SCV001727473 | benign | Neuronal ceroid lipofuscinosis 13 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625316 | SCV001876392 | benign | Neuronal ceroid lipofuscinosis 13 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000675400 | SCV005318625 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000625316 | SCV000745743 | benign | Neuronal ceroid lipofuscinosis 13 | 2016-04-22 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675400 | SCV000801073 | benign | not provided | 2015-10-22 | no assertion criteria provided | clinical testing |